Related Experiment Video
Updated: Jun 17, 2026

09:03
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
2.7K
Enzyme inhibition-enabled CRISPR/Cas12a biosensing system for heparin-related non-nucleic acid biomarkers
Ruo Ma1,2,3, Wenjiao Fan1,2,3, Yueran Wang1,2,3
1Key Laboratory of Applied Surface and Colloid Chemistry Ministry of Education, P. R. China.
Abstract:
In contrast to conventional CRISPR/Cas12a systems, which rely on complex functional nucleic acids, protein switches, or allosteric transcription factor (aTF)-based signal conversion for non-nucleic acid analysis, this work achieves more facile quantification of non-nucleic acid biomarkers through a novel heparin-mediated Cas12a inhibition mechanism.

